Page last updated: 2024-08-25

rosiglitazone and n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin

rosiglitazone has been researched along with n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aay, N; Aoyama, R; Arcalas, A; Bentzien, F; Cancilla, B; Chan, V; Du, H; Finn, P; Galan, A; Hanel, A; Harrison, A; Kearney, P; Koltun, ES; Lamb, P; Larson, CJ; Mohan, R; Nachtigall, J; Nuss, J; Ogilvie, K; Plonowski, A; Qian, F; Richards, S; Rosen, J; Tam, D; Wang, T; Won, KA; Yakes, M; Zhang, J; Zhang, W1

Other Studies

1 other study(ies) available for rosiglitazone and n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin

ArticleYear
Discovery and characterization of an inhibitor of glucosylceramide synthase.
    Journal of medicinal chemistry, 2012, May-10, Volume: 55, Issue:9

    Topics: Adipose Tissue, White; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Gangliosides; Glucose Tolerance Test; Glucosyltransferases; Humans; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Nude; Phenylalanine; Rats; Rats, Sprague-Dawley; Rats, Zucker; Structure-Activity Relationship; Triglycerides

2012